News Hub | News Direct

All Industries


Article thumbnail News Release

Yandex develops and open-sources an LLM training tool that saves up to 20% of GPU resources

Yandex

Yandex introduces YaFSDP, a method for faster and more efficient large language model (LLM) training. Potentially saving users hundreds of thousands of dollars per month. Available free. Yandex, a global tech company, recently introduced YaFSDP, an open-source method for training large language models (LLMs). YaFSDP is currently the most effective publicly available tool for enhancing GPU communication and reducing memory usage in LLM training, offering a speedup of up to 26% compared to FSDP, depending on the architecture and number of parameters. Reducing the training time for LLMs through the use of YaFSDP can result in savings of up to 20% in GPU resources. “Currently, we're actively experimenting with various model architectures and parameter sizes to expand YaFSDP’s versatility,” noted Mikhail Khruschev, a senior developer at Yandex and part of the team behind YaFSDP. “We are thrilled to share our developments in LLM training with the global ML community, contributing to increased accessibility and efficiency for researchers and developers worldwide.” The case for YaFSDP LLM training is a time-consuming and resource-intensive process. Machine learning engineers and companies that develop their own LLMs invest significant time and GPU resources — which equals money — in training these models. The larger the model, the greater the time and expenses associated with its training. Yandex’s YaFSDP works by eliminating GPU communication inefficiencies, ensuring that training requires only necessary processor memory and making GPU interactions uninterrupted. YaFSDP optimizes learning speed and performance, enabling AI developers worldwide to use less computing power and GPU resources when training their models. For instance, in a pre-training scenario involving a model with 70 billion parameters, using YaFSDP can save the resources of approximately 150 GPUs, which translates to roughly $0.5 to $1.5 million (depending on the virtual GPU provider or platform) in potential monthly savings. YaFSDP’s training efficiency YaFSDP, an enhanced version of FSDP, outperforms the FSDP method in the most communication-heavy stages of LLM training like pre-training, alignment, and fine-tuning. The final speedup shown by YaFSDP on Llama 2 and Llama 3 demonstrates significant improvements in training speed, reaching 21% and 26% on Llama 2 70B and Llama 3 70B respectively. “YaFSDP has shown impressive results on models ranging from 13 to 70 billion parameters, with particularly strong performance in the 30 to 70 billion range,” said Mikhail Khruschev. “Currently, YaFSDP is best suited for widely-used open-source models based on the LLaMA architecture.” YaFSDP isn’t Yandex’s first open-source tool. The company has previously shared several other tools that have become popular with the ML community, including: CatBoost, a high-performance library for gradient boosting on decision trees. YTsaurus, a big data platform for distributed storage and processing. AQLM, one of the most advanced quantization algorithms for extreme compression of large language models, developed jointly by Yandex Research, HSE University, IST Austria, and NeuralMagic. Petals, a library designed to simplify the process of training and fine-tuning LLMs, developed in a collaboration involving Yandex Research, HSE University, University of Washington, Hugging Face, ENS Paris-Saclay, and Yandex School of Data Analysis. Accessing YaFSDP YaFSDP is freely available on Github. – – – – – For Reference During large language model (LLM) training, developers have to efficiently manage three primary resources: computing power, processor memory, and processor communications. YaFSDP conserves the first two, which helps to accelerate the LLM training process. LLM training relies on numerous GPUs organized into clusters — arrays of interconnected graphics processors that can perform the vast number of calculations necessary to train models with billions of parameters. Distributing computations among processors within a cluster requires constant communication, which often becomes a "bottleneck", slowing the training process and resulting in inefficient use of computing power. To overcome this bottleneck, Yandex developers created YaFSDP, a method that improves GPU communication and optimizes learning speed and performance. When combined with Yandex’s other performance-enhancing solutions, the method accelerated the training process by up to 45% for some of its models. YaFSDP works by eliminating GPU communication inefficiencies, which leads to optimized network usage and reduced memory load. It ensures that training requires only necessary processor memory and makes GPU interactions uninterrupted, facilitating further optimizations like minimizing processor communication time. This leads to a significant enhancement in both performance and memory efficiency. The YaFSDP method can be used effectively in transformer-based text generative models with multiple layers (multilayer perceptrons), mostly represented by LLaMA-like models. In a pre-training scenario involving a model with 70 billion parameters, using YaFSDP can save the resources of approximately 150 GPUs. When compared to FSDP, the final speedup shown by YaFSDP on Llama 2 and Llama 3 demonstrates significant improvements in training efficiency. About Yandex Yandex is a global technology company that builds intelligent products and services powered by machine learning. The company’s goal is to help consumers and businesses better navigate the online and offline world. Since 1997, Yandex has been delivering world-class, locally relevant search and information services and has also developed market-leading on-demand transportation services, navigation products, and other mobile applications for millions of consumers across the globe. Contact Details NettResults Media Team media@nettresults.com

June 12, 2024 08:55 AM Eastern Daylight Time

Article thumbnail News Release

How Super League Enterprise (NASDAQ: SLE) Is Pioneering 3D Immersive Platforms As The Marketing Channel Of The Future

Benzinga

By James Blacker, Benzinga Welcome To The 3D Web Digital advertising is undergoing a profound shift toward immersive engagement. Platforms such as Roblox have shown the huge potential for engagement through the 3D Web, where digital environments are highly immersive and interactive. The average Roblox user, for instance, spends more than 156 minutes a day on the platform, compared to an average of 95 minutes per day spent by TikTok users. As the metaverse continues to capture global attention, Super League Enterprise (NASDAQ: SLE) stands at the forefront of a digital frontier, effectively offering brands an operating system for the 3D Web. The suite of development, distribution, monetization and optimization tools it has developed are giving brands the ability to engage users through dynamic content experiences across the largest immersive platforms, such as Roblox (NYSE: RBLX), Microsoft’s (NASDAQ: MSFT) Minecraft and Fortnite Creative. Brands have turned to end-to-end activation partners to gain a foothold in the new environments where massive audiences are gathering to socialize, play, explore, collaborate, shop, learn and create, said Ann Hand, CEO of Super League. “The secular shift in advertising is unstoppable,” Hand said. “Immersive engagement, new experiences and consistent digital presence are enabling brands to connect with young consumers in highly customized and personalized ways.” In 2021 alone, more than $10 bn was raised by metaverse-related companies, while the global value creation opportunity from the metaverse is expected to be in the trillions by 2030. Super League recognized this trend early and positioned itself as a leader in creating immersive experiences that resonate with Generation Z and Alpha. This strategic positioning has also translated into financial growth, with Q1 2024 revenue reaching $4.2 million, a 27% year-over-year increase following record revenue in the previous quarter and full-year 2023. The company also managed to cut operating expenses by 22% in the first quarter of 2024 thanks to significant cost reduction initiatives, representing a saving of $1.5 million compared to the same period of 2023 and narrowing the net loss by 26% Strategic Partnerships And Major Collaborations Imagine stepping into a virtual store operated by Skechers (NYSE: SKX). In May, Super League announced a partnership with Skechers to open the company’s first virtual store through an immersive experience in Roblox. In the first five weeks, there have been 3.4 million visits to the store, 4 million try-ons and nearly 45 million impressions generated. A couple of weeks later, fans could have front-row seats for Post Malone’s Live at Le Louvre event as it streamed live on Roblox. In the last 30 days, Super League made those things possible and its tools for immersive products and experiences continue to put brands where an emerging generation of online consumers are spending significant time. In 2023, Super League served almost 100 brands through bespoke worlds, custom integrations into Roblox, Minecraft and Fortnite, as well as seven-figure media campaigns on these platforms. In March this year, Super League announced a partnership with Chartis, which offers a suite of tools for creators to build original games and experiences within Fortnite Creative. The partnership allows the company to develop end-to-end integrations into more than 100 Fortnite maps, tapping into the Chartis Network, a coalition of developers with more than 157 million monthly plays and nearly one billion monthly impressions. In the same month, Super League announced that it has partnered with GSTV to integrate gaming content into GSTV’s video network at fuel retailers across the U.S., which reaches 115 million unique adults a month across more than 29,000 locations. Super League’s Metaburst gaming news will be featured on GSTV, keeping viewers informed about the latest in the 3D web, virtual worlds and platforms like Roblox and Fortnite. The partnership also aims to blend physical and digital retail engagement, offering brands innovative ways to engage consumers. The Future Of Brand Engagement The metaverse is here to stay, creating an opportunity for marketers to innovate and engage with consumers in previously unimaginable ways. Super League Entertainment's pioneering efforts are setting the stage to enable forward looking brands to create sizable, immersive marketing channels to connect with an emerging generation of consumers. Featured photo by Alex Haney on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

June 12, 2024 08:30 AM Eastern Daylight Time

Image
Article thumbnail News Release

DPH BIOLOGICALS LAUNCHES MICROBIAL NUTRIENT ENHANCER DESIGNED TO UNIFORMLY COVER BULK DRY FERTILIZERS

DPH Biologicals

DPH Biologicals, a leading developer and supplier of agricultural biologicals, has launched Envelix TM Prime, a patented, biological nutrient enhancer designed to uniformly cover bulk dry fertilizer, delivering a robust biological consortium paired with fertilizer in a single application. “Envelix Prime enables both retailers and growers to seamlessly unlock the value of biologicals on a broader scale,” said Mick Messman, DPH Bio President & CEO. “Just one pound of Envelix Prime evenly covers a ton of dry fertilizer, giving retailers a way to differentiate their fertilizer blends with biology while giving growers a single-purchase, single application route to enhanced performance and an increased return on their fertilizer investment.” Envelix Prime contains naturally occurring beneficial bacterial and fungal microorganisms designed to accelerate and maximize fertility release using a patented carrier to adhere microorganisms to the fertilizer prill. In a tissue sample taken from a 2023 corn trial at the V3 leaf stage, Envelix Prime increased nutrient uptake of several macro and micronutrients when applied to MESZ fertilizer, including: An 18% increase in phosphorus, A 10% increase in sulfur. A 9% increase in boron. An 8% increase in copper. Envelix Prime is DPH Bio’s first product to be powered by Prime™, a one-of-a-kind, patented spore priming technology that germinates beneficial bacteria faster, and in harsher conditions, enabling more consistent biological performance. In a recent corn trial, Prime enabled more than 70% of spores to germinate at temperatures as high as 98.6 degrees, while those without Prime germinated less than 10%. Additionally, nearly all spores with Prime germinated in high salt environments, while those that were not treated with Prime did not germinate. Envelix Prime mixes seamlessly with MAP, DAP & Urea, offering improved flowability and less bridging at application. “We are excited to get Envelix Prime out on the broad acre this fall enabling many growers the opportunity to experience the benefits of biologicals for the first time. This integrated approach requires no change in practice for the grower and, with the addition of Prime, we are confident that growers will consistently see the benefits this dynamic product unlocks both in the field and to their bottom line,” said Messman. Envelix Prime is available now to retail partners and fertilizer blending facilities. For more information about DPH Bio’s technology platforms – RegenAphex™ and Prime, as well as DPH Bio’s expanded product portfolio, visit www.dphbio.com. About DPH Biologicals DPH Biologicals, LLC attracts, develops and scales technologies improving broad market access and simplifying the grower experience with biologicals. Based on investments in scientific research, field testing, partner relationships and product development, and leadership-owned since 2024, DPH Bio yields success through science and relationships, standing at the leading edge of clarity, trust and proven, profitable solutions for agricultural biologicals. For more information, visit www.dphbio.com. Contact Details AgTech PR for DPH Biologicals Jennifer Goldston jennifer@agtechpr.com Company Website http://www.dphbio.com

June 12, 2024 08:30 AM Eastern Daylight Time

Image
Article thumbnail News Release

BestGrowthStocks.com Issues Comprehensive Evaluation of MediaCo Holding Inc

MediaCo Holding Inc

NEW YORK, NY / News Direct/ June 12th, 2024 / Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued a comprehensive evaluation of MediaCo Holding Inc. a publicly listed media company that super-serves communities throughout the country. MediaCo Holding Inc (NASDAQ: MDIA) has recently caught the attention of many investors following an acquisition of all of Estrella Media’s network, content, digital, and commercial operations. Among the Estrella Media brands that have joined MediaCo are the EstrellaTV network and its influential linear and digital video content business, and Estrella Media’s expansive digital channels, including its four FAST channels – EstrellaTV, Estrella News, Cine EstrellaTV, and Estrella Games – and the EstrellaTV app. The transaction closed on April 17, 2024. Best Growth Stock's full report breaks through the noise and offers a comprehensive analysis of MediaCo’s operations, Estrella Media’s operations, financials, share structure, chart setup, potential catalysts, recent business combination, and much more. Access this full analysis free: https://bestgrowthstocks.com/access-mdia-analysis/ (If you cannot click the link above, copy and paste to your browser may be required) Access this full analysis free: https://bestgrowthstocks.com/access-mdia-analysis/ (If you cannot click the link above, copy and paste to your browser may be required) About MediaCo MediaCo Holding Inc. (“MediaCo”) is a publicly listed media company (NASDAQ: MDIA) that super-serves communities throughout the country. MediaCo owns and operates two iconic radio stations in New York City, HOT 97 (WQHT-FM) and WBLS-FM, which boast extensive digital reach across the US. The company primarily generates revenue from advertising sales, program syndication and live events. To learn more about MediaCo, visit www.mediacoholding.com. About Best Growth Stocks Best Growth Stocks is a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing our exclusive ai-assisted research. BGS is also a financial news provider, focused on giving investors direct access to CEOs of promising, publicly-traded companies, and market experts. Our CEO interviews aim to answer the questions that rest on the minds of current and future shareholders. This is not to be construed as financial advice. Please consult with a licensed financial advisor before making any investment decisions. Contact Details Best Growth Stocks Steve Macalbry Editor@bestgrowthstocks.com

June 12, 2024 08:30 AM Eastern Daylight Time

Image
Article thumbnail News Release

JasmyCoin Holders Jump to Raboo Presale Amid Dogecoin's Rising Wave

Total Media

Dogecoin and JasmyCoin price share different trajectories while still offering good trading opportunities. The current Dogecoin forecast is bullish, while JasmyCoin price action continues to sizzle. However, one new contender has emerged in the form of AI/SocialFi meme coin presale sensation Raboo, which analysts can go on a 100x tear in 2024. Read up to find out why experts predict Raboo could outperform even the most bullish JasmyCoin price prediction, and Dogecoin forecast this year. New contenders coming for Dogecoin’s crown Dogecoin lays claim to being the OG meme coin, creating the blueprint for every single meme coin within the $57.6 billion sector. Dogecoin has come a long way from being an ironic take on the “wild west” era of the crypto world, growing to a $20 billion market cap. Early Dogecoin investors have made millions of times over their initial investments, especially those that sold at Dogecoin’s all-time high of $0.73 back in 2021. Today, Dogecoin serves as an “index” for the meme coin market. However, the current Dogecoin forecast is bearish due to its large market cap, which severely restricts its growth potential. The Dogecoin forecast for 2024 is one of limited gains, with more capital flowing into lower-cap opportunities that have larger room to grow. The most bullish Dogecoin forecast predicts a 3x to 5x gain for the token should the next bull run materialize. JasmyCoin price prediction for 2024 looking up JasmyCoin has turned in almost a 950% YTD figure as of press time, firmly outdoing the Dogecoin forecast within the same 12-month period. Here’s the cool thing about JasmyCoin: despite the 10x growth in the past year, The current JasmyCoin price is still 99.2% from its February 2021 all-time high of $4.99, indicating a potentially limitless growth trajectory. That is, of course, if JasmyCoin bulls continue pushing prices as they have over the past year. If they manage to do so, JasmyCoin could outperform the Dogecoin forecast for 2024. However, JasmyCoin has a $1.78 billion market cap, with early holders selling off in favor of projects like Raboo. Raboo presale surges into Stage 4 with a 60% rally Crypto presales offer a can’t-miss buying opportunity, considering it is during this phase when token prices are going to be as low as they possibly can be. Especially meme coins with an innovative utility like Raboo. Finding presale opportunities with the potential for 100x gains like Raboo can be a needle in a haystack. But now, prospective investors could get in on a low-cap blue chip at a price of just $0.0048. Raboo is a meme coin featuring AI-powered SocialFi utility. Using Rabooscan, the platform’s AI-enabled meme generator, users can create memes and NFTs designed to engage the Raboo community and grow it by attracting new joiners by disseminating them through social media. In doing so, users can earn Raboo tokens in exchange for their efforts. With the meme coin market sitting at a $58 billion market cap—with limitless growth potential in 2024 and beyond—Raboo is a rare opportunity to get in on a legitimate 100x moon shot set to outperform both Dogecoin forecast and JasmyCoin price this year. Raboo users can also stake their $RABT tokens or provide liquidity for passive income, and its deflationary tokenomics ensures a constantly stable price with the potential to skyrocket in price at any given time. Conclusion With token prices available at just $0.0048, Raboo blows JasmyCoin and Dogecoin out of the water as far as upside potential in 2024 is concerned. Don’t miss out on an opportunity to get in on the ground floor of a project that could go all the way to the top this year—join the Raboo presale today. You can participate in the Raboo presale here. Telegram: https://t.me/RabootokenPortal Twitter: https://twitter.com/Raboo_Official Contact Details Total Media Solutions media@Totalsolutionspr.io

June 12, 2024 06:30 AM Eastern Daylight Time

Image
Article thumbnail News Release

Therma Bright’s Investment Case Just Got Stronger As Approval On Permanent Insurance Codes Gets Closer

TBRIF

Therma Bright (TSXV:THRM) (OTCQB:TBRIF), a developer of a wide range of leading edge, proprietary diagnostic and medical device technologies that address some of today's most important medical and healthcare challenges, appears to be positioned for major growth based on one important upcoming catalyst. For some background, Therma Bright (TSXV:THRM) (OTCQB:TBRIF) sells Venowave, a compact, battery operated peristaltic pump that generates a wave-form motion. When worn below the knee and strapped to the calf, the resulting compression of the calf causes an increased upward volumetric displacement of venous and lymph fluid. The Venowave is FDA approved for 10 indications, including: Management of Post Thrombotic Syndrome, Prevention of Deep Vein Thrombosis (DVT / blood clots), treatment of Chronic Venous Insufficiency, as well as other conditions related to poor circulation in the extremities.It seems that the company is set to receive a newly issued, HCPCS Level II code to identify it’s Venowave device,which will be instrumental in driving revenue growth. HCPCS codes are a set of health care procedure codes used in the United States to standardize the reporting of medical procedures, services and devices. These codes are essential for billing and reimbursement purposes within the Medicare and Medicaid programs, and are also used by other healthcare insurers in the United States, including private insurance companies. Additionally, a preliminary Medicare Payment determination will be made for this new HCPCS code. If the Venowave is purchased outright, Medicare and Medicaid will reimburse $1,199 USD. If the unit is rented to the patient, Medicare and Medicaid will pay $78.05 USD / month for up to 13 months, for a total of $819.55 USD. These are very favourable numbers for Therma Bright when taking into account the manufacturing cost of Venowave. Additionally, private insurers such as blue cross blue shield, UnitedHealth Group, etc., also use these codes as guidelines to determine reimbursement payouts. Why is this so important? Previously, Venowave was placed into the E0676 HCPCS code. E0676 is a miscellaneous code with no set reimbursement, meaning that when Venowave is billed for under this code, Medicare and Medicaid, as well as private insurance companies will default to a $0 reimbursement. While it is possible to submit a package of medical necessity under this code, with a detailed explanation of the patients’ condition and why it should be reimbursed, the reality is that most physicians or prescribing parties will not go through this exercise as they are not reimbursed for the time and trouble it takes. Therma Bright experienced a similar situation with the temporary codes it was approved to sell Venowave under in 2023 – Without the prescribing party submitting a package of medical necessity, Venowave by default will not be paid for. Additionally, these reimbursement issues are a barrier to prescribing parties recommending Venowave, as they are not able to tell their patients if the device will be paid for. Physicians tend to shy away from prescribing devices in these categories, as they could leave their patient with a large unexpected medical bill, reflecting badly on the prescribing party. This new HCPCS code combined with the preliminary payment determination establishes a fixed payout for Venowave across public and private insurers in the United States, eliminating friction in payments as well as hesitancy by the prescribing parties in recommending the device. Therma Bright expects to receive this new HCPCS code and payment determination after the biannual CMS meeting which was held at the end of May, 2024. Venowave differentiates itself from other available compression products in a number of ways. Currently, pneumatic devices and simple products that squeeze the leg make up the majority of the compression market. Inexpensive portable compression devices simply squeeze and release the calf, and do not actively move fluid upwards towards the heart. Sequential compression devices are proven very effective, however they are not portable. Sequential compression devices have tubes attached to an air compressor which inflates chambers in sequence, providing sequential compression. Typically these devices can only be used while lying in bed, on a couch or in a similar position, and do not allow the patient to remain ambulatory. Venowave combines the best of both worlds, providing sequential compression without the use of tubes or wires, allowing the patient to remain completely ambulatory while receiving treatment. Additionally, Venowave is quiet, so patients can continue to receive treatment while they are sleeping or otherwise resting. Currently in the United States an estimated 25 million people are living with some form of Chronic Venous insufficiency. Most go untreated or rely on simple compression stockings for some form of minor relief, as proper treatment via sequential compression devices is too cumbersome and expensive. The issuance of this new HCPCS code and payment determination opens up these patients to the Venowave, a new and portable form of treatment that will not cost them anything out of pocket. This market alone, along with the management of Post Thrombotic Syndrome and prevention of primary thrombosis is potentially huge. Additionally, Therma Bright is working towards securing reimbursement for DVT prevention. While Medicare and Medicaid do not pay for DVT prevention, private insurers do. Therma Bright is confident that the issuance of this new HCPCS code and payment determination will help patients access Venowave for DVT prevention via their private health insurance, which is another huge addressable market in the United States. During the last year, Therma Bright has been meeting with potential distributors across the United States. Many have indicated interest in the Venowave pursuant to a positive outcome with regards to the HCPCS coding. Therma Bright currently has over 2000 Venowave units in inventory, which they expect can be moved right away upon the issuance of the HCPCS code. After these initial 2000 units are sent to distributors, placed on patients, and reimbursement received, Therma Bright conservatively estimates moving 500-1000 units / month. Given the high margin on Venowave, this will fare well for the company. As Venowave is a high margin product, the company is looking at the possibility of setting up a manufacturing operation in either the U.S, Canada or Mexico which would allow it to sell to the VA in the US. This would open up yet another large market for Venowave in the United States. For investors who may be interested in Therma Bright, it is important to note that Venowave isn’t its only product. The company also has respiratory health and consumer health product portfolios. The respiratory health product portfolio features the Digital Cough Test (DCT) app created by Therma Bright (TSXV:THRM) (OTCQB:TBRIF) and AI4LYF. The app uses artificial intelligence to detect multiple respiratory diseases by analyzing a person’s cough sound and has shown a high accuracy rate. The app is currently in the process of securing a 513g FDA clearance, which will allow the company to charge for Remote Therapeutic Monitoring (RTM) and be used for patient reimbursement. The consumer health product portfolio features devices designed for pain relief, cold sore prevention and insect bite relief. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and expects to be compensated by Therma Brite to assist in the production and distribution of content related to TBRIF. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Inc Mark McKelvie +1 585-301-7700 mark@razorpitch.com Company Website http://RazorPitch.com

June 12, 2024 06:00 AM Eastern Daylight Time

Article thumbnail News Release

The Diverse Holdings of the Industrial ETF XLI

Select Sector SPDR

The Industrial Select Sector SPDR Fund ( XLI ) offers an investment opportunity within the dynamics of the industrial sector. XLI follows an index of industrial sector stocks within the S&P 500, weighted by modified market capitalization. With assets under management exceeding $18 billion, it boasts a low annual expense ratio of 0.09%*, offering an efficient and accessible route to the industrial sector. The top 10 holdings & weightings** for XLI: Starting with GE Aerospace at 4.75%, followed by Caterpillar at 4.55%, RTX Corporation at 3.78%, Union Pacific at 3.75%, Honeywell International at 3.52%, Eaton at 3.51%, Uber Technologies at 3.51%, Boeing at 2.69%, Lockheed Martin at 2.67%, and Automatic Data Processing at 2.66%. XLI ETF Industry and Sector Overview The variety of related industries are represented in the burgeoning industrial sector. Aerospace & Defense: The XLI ETF includes prominent companies within the aerospace and defense sector, positioning investors to have access to companies in this industry. Electrical Equipment Manufacturers: The fund's holdings feature leading electrical equipment manufacturers with their technological advancements and innovations within this sector. Construction & Engineering Firms: XLI provides exposure to renowned construction and engineering firms, allowing investors to tap into the ongoing infrastructure development and urbanization trends. Industrial Machinery Companies: The ETF also encompasses key players in the industrial machinery segment, enabling investors to participate in the machinery and equipment manufacturing landscape. Building Products: XLI encompasses a diverse range of building product companies, offering exposure to the construction and real estate market dynamics. As the industrial landscape continues to evolve, XLI emerges as a compelling choice for investors seeking exposure to the dynamic industrial sector. DISCLAIMER: This is a work of research and should not be taken as investment or financial advice. Therefore, Select Sector SPDRs or the publisher is not liable for any decision made based on the publication. About the Company: Select Sector SPDR ETFs offer flexibility and customization opportunities. Many investors have similar outlooks, but no two are exactly alike. Select Sector SPDR ETFs let investors select the sectors that best meet their investment goals. *Ordinary brokerage fees apply **Holdings, Weightings & Assets as of 5/31/24 subject to change DISCLOSURES The S&P 500 Index is an unmanaged index of 500 common stocks that is generally considered representative of the U.S. stock market. The index is heavily weighted toward stocks with large market capitalizations and represents approximately two-thirds of the total market value of all domestic common stocks. The S&P 500 Index figures do not reflect any fees, expenses or taxes. An investor should consider investment objectives, risks, fees and expenses before investing. One may not invest directly in an index. Transparent ETFs provide daily disclosure of portfolio holdings and weightings All ETFs are subject to risk, including loss of principal. Sector ETF products are also subject to sector risk and non-diversification risk, which generally will result in greater price fluctuations than the overall market. Diversification does not eliminate risk. An investor should consider investment objectives, risks, charges and expenses carefully before investing. To obtain a prospectus, which contains this and other information, call 1-866-SECTOR-ETF (732-8673) or visit www.sectorspdrs.com. Read the prospectus carefully before investing. ALPS Portfolio Solutions Distributor, Inc., a registered broker-dealer, is distributor for the Select Sector SPDR Trust. Media Contact: Company: Select Sector SPDRs Contact: Dan Dolan* Address: 1290 Broadway, Suite 1000, Denver, CO 80203 Country: United States Email: dan.dolan@sectorspdrs.com Website: https://www.sectorspdrs.com/ *Dan Dolan is a Registered Representative of ALPS Portfolio Solutions Distributor, Inc. ALPS Portfolio Solutions Distributor, Inc., a registered broker-dealer, is the distributor for the Select Sector SPDR Trust. SEL007585 EXP 8/31/24 Contact Details Dan Dolan +1 203-935-8103 dan.dolan@sectorspdrs.com Company Website https://www.sectorspdrs.com/

June 12, 2024 05:00 AM Eastern Daylight Time

Article thumbnail News Release

AGC Biologics & Chief Executive Officer Patricio Massera Announce Plans for Him to Step Down

AGC Biologics

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced that its Chief Executive Officer (CEO), Patricio Massera, will be stepping down from his role effective June 30. Patricio Massera joined the company in 2012, as General Manager of the Copenhagen site at CMC Biologics A/S. He later served as Chief Operating Officer of CMC Biologics at its Seattle headquarters. He held the same role after CMC Biologics was acquired by AGC Inc. and formed AGC Biologics. Mr. Massera was appointed CEO in 2019. He also served as an Executive Officer of the AGC Life Science Company, the Life Science Division of AGC Inc. During his tenure as CEO, Mr. Massera spearheaded several initiatives that elevated AGC Biologics' global business and brand. His work and achievements include key milestones such as navigating the COVID-19 pandemic, acquiring Molecular Medicine S.p.A. (“MolMed”) in Milan to create AGC Biologics’ Global Cell and Gene business, and acquiring facilities in Boulder and Longmont, Colorado to establish new large-scale commercial mammalian capacity and cell and gene services in North America. Mr. Massera also directed the company’s long-standing commitment to investing in single-use technology to ensure AGC Biologics could address the evolving needs of pharmaceutical companies using any platform process to develop new drug candidates. “Over the past 12 years, I have had the privilege of experiencing the most vibrant and remarkable professional position of my life. CMC Biologics, and later AGC Biologics, have provided me with countless opportunities. I have met incredible individuals driven by the desire to build a better world, all sharing the common purpose of enabling our partners to cure life-threatening diseases and bring hope to life.” Massera said. “During this journey, we have managed to grow the business multiple times. However, like all great stories, every book has an end. In this case, it is just a chapter that finishes. AGC Biologics has a long and brilliant journey ahead, but it is time for someone else to write the next chapter.” The new CEO search process is underway. In light of this transition, AGC Biologics is pleased to share Tadashi Murano, President of the AGC Life Science Company, will serve as interim CEO. He brings several decades of experience in global leadership roles within AGC Inc. across various business entities. For more information on AGC Biologics, visit www.agcbio.com. About AGC Biologics: AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partners, every step of the way. We provide world-class development and manufacture of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our global network spans the U.S., Europe, and Asia, with cGMP-compliant facilities in Seattle, Washington; Boulder and Longmont, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba, Japan. We currently employ more than 2,500 Team Members worldwide. Our commitment to continuous innovation fosters the technical creativity to solve our clients’ most complex challenges, including specialization in fast-track projects and rare diseases. AGC Biologics is a part of AGC Inc.’s Life Science Company. The Life Science company runs more than 10 global facilities focused on biopharmaceuticals, advanced therapies, small molecule active pharmaceutical ingredients, and agrochemicals. To learn more, visit www.agcbio.com. Contact Details Nick McDonald +1 425-419-3555 nmcdonald@agcbio.com Company Website https://www.agcbio.com/

June 12, 2024 12:00 AM Pacific Daylight Time

Article thumbnail News Release

Benchmark International Successfully Facilitated the Transaction Between Tygra Industries, LLC and Fugue Capital

Benchmark International

Benchmark is pleased to announce the transaction between Tygra Industries, LLC and Fugue Capital. The transaction represents a strategic expansion for Fugue Capital as they work to achieve scale through acquisitions. Tygra Industries, LLC, also known as Tri-Tex Cabinets, is a custom cabinetry manufacturer specializing in residential kitchen, bathroom, closet, office, and mud and laundry room installations. Founded in 1967 by the Dane family, Tri-Tex Cabinets was acquired by Tygra Industries, LLC in 2015. Since then, the company has experienced continued success and growth. Fugue Capital, a private equity firm, focuses on energy, construction, professional services, and agriculture companies in Texas and surrounding regions. Fugue Capital prides itself on its industry experience, strategic initiatives, and ability to help companies in the lower middle market continue to grow and expand. "It was exciting to walk with our client through the different conversations, offers, and questions that had arisen regarding their opportunity. Our team enjoyed watching both Fugue Capital and Tygra Industries explore the mutual synergies they shared and the working relationship that has been formed between both parties to allow Fugue Capital to run the next race. We wish both parties the best of luck in their future endeavors." - Managing Director, Amy Alonso, Benchmark International Americas: Sam Smoot at +1 (813) 898 2350 / Smoot@BenchmarkIntl.com Europe: Michael Lawrie at +44 (0) 161 359 4400 / Lawrie@BenchmarkIntl.com Africa: Anthony McCardle at +27 21 300 2055 / McCardle@BenchmarkIntl.com ABOUT BENCHMARK INTERNATIONAL: Benchmark International is a global M&A firm that provides business owners with creative, value-maximizing solutions for growing and exiting their businesses. Benchmark International has handled over $11 billion in transaction value across various industries from offices across the world. With decades of M&A experience, Benchmark International’s transaction teams have assisted business owners with achieving their objectives and ensuring the continued growth of their businesses. The firm has also been named the Investment Banking Firm of the Year by The M&A Advisor and the Global M&A Network as well as the #1 Sell-side Exclusive Privately-held M&A Advisor in the World by Pitchbook and Refinitiv's Global League Tables. Contact Details Brittney Zoeller +1 813-898-2350 zoeller@benchmarkintl.com Company Website https://www.benchmarkintl.com/

June 11, 2024 04:32 PM Eastern Daylight Time

Image
1 ... 144145146147148 ... 3752